Blockchain Registration Transaction Record

NeuroOne Reports Record $9.1M Revenue, 163% Growth in FY2025

NeuroOne Medical Technologies reports record $9.1M revenue with 163% growth driven by OneRF Ablation system for epilepsy treatment. Learn about their neurological care innovations.

This development represents significant progress in neurological treatment technology that could transform care for millions suffering from epilepsy and other neurological disorders. The substantial revenue growth indicates strong market adoption of NeuroOne's minimally invasive ablation system, suggesting healthcare providers are increasingly embracing advanced technologies that offer improved patient outcomes. For patients with treatment-resistant epilepsy, this technology provides new hope for effective intervention with potentially fewer complications than traditional surgical approaches. The financial success also signals investor confidence in neurological medical technology, which could accelerate further innovation and competition in a field that has seen limited treatment advancements in recent decades. As neurological disorders affect approximately 1 billion people worldwide, breakthroughs in minimally invasive treatments could substantially reduce healthcare costs while improving quality of life for patients and their families.